Maxcyte (MXCT) Acquisitions (2025)

Maxcyte (MXCT) reported Acquisitions of $1.8 million for Q1 2025.

Maxcyte (MXCT) has 1 years of Acquisitions data on file, last reported at $1.8 million in Q1 2025.

  • Quarterly Acquisitions changed N/A year-over-year to $1.8 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $1.8 million (changed N/A YoY) and the FY2025 annual result came in at $1.8 million, changed N/A from the prior year.
  • Acquisitions held at $1.8 million in Q1 2025 per MXCT's latest filing.
  • Across five years, Acquisitions topped out at $1.8 million in Q1 2025 and bottomed at $1.8 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 22.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 523.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -268.10 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 2.30 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Maxcyte 129.85 Mn 129.85 Mn 8.08 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2025 1.77 Mn